ABC.N
Latest Trade
84.63USDChange
1.63(+1.96%)Volume
537,662Today's Range
-
85.2052 Week Range
-
94.84As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 83.00 |
|---|---|
Open | 83.25 |
Volume | 537,662 |
3M AVG Volume | 27.94 |
Today's High | 85.20 |
Today's Low | 82.99 |
52 Week High | 94.84 |
52 Week Low | 69.36 |
Shares Out (MIL) | 208.33 |
Market Cap (MIL) | 17,328.52 |
Forward P/E | 11.79 |
Dividend (Yield %) | 1.92 |
Emmaus Life Sciences Announces Addition Of Oncology Supply As Distributor Of Endari
McKesson, Cardinal, Amerisourcebergen Propose Paying $10 Bln To Settle Claims They Helped Fuel Opioid Epidemic - Bloomberg
Amerisourcebergen Reports Fiscal 2019 Third Quarter Results
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
Industry
Biotechnology & Drugs
Executive Leadership
Steven H. Collis
Chairman of the Board, President, Chief Executive Officer
James F. Cleary
Chief Financial Officer, Executive Vice President
Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Gina K. Clark
Executive Vice President, Chief Communications & Administration Officer
Dale Danilewitz
Executive Vice President, Chief Information Officer
Price To Earnings (TTM) | 19.89 |
|---|---|
Price To Sales (TTM) | 0.10 |
Price To Book (MRQ) | 5.80 |
Price To Cash Flow (TTM) | 12.65 |
Total Debt To Equity (MRQ) | 150.73 |
LT Debt To Equity (MRQ) | 145.18 |
Return on Investment (TTM) | 8.71 |
Return on Equity (TTM) | 2.22 |
AmerisourceBergen has lost a bid to keep secret material related to the drug distributor's internal program for monitoring for suspicious orders in a lawsuit by New York's attorney general accusing the company of fueling the opioid epidemic.
AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.
AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Drug distributor AmerisourceBergen Corp <ABC.N> posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent.
* AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS
Drug distributor AmerisourceBergen Corp on Wednesday posted a 30 percent fall in second-quarter profit hurt by high operating expenses.
* PRODUCTION AT PHARMEDIUM'S MEMPHIS OUTSOURCING FACILITY REMAINS VOLUNTARILY SUSPENDED
Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.
* AMERISOURCEBERGEN SAYS STOCKHOLDERS REJECTED PROPOSAL TO URGE BOARD TO REPORT ON GOVERNANCE MEASURES IMPLEMENTED RELATED TO OPIOIDS - SEC FILING Source text: (http://bit.ly/2HZhCXW) Further company coverage:
* TALKS BETWEEN WALGREENS AND AMERISOURCEBERGEN ABOUT AN ACQUISITION OF THE WHOLESALE DRUG DISTRIBUTOR HAVE ENDED WITHOUT AN AGREEMENT - CNBC, CITING SOURCES Source text: http://cnb.cx/2HP99qj Further company coverage:
Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.
Walgreens' potential move to buy a drug distributor in which it already has a 26 percent stake has some analysts questioning the logic and wondering if it would be enough to compete in an evolving U.S. healthcare sector.
The largest U.S. drugstore operator Walgreens Boots Alliance Inc has made a takeover approach to drug distributor AmerisourceBergen Corp, the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.
Walgreens Boots Alliance Inc has made a takeover approach for U.S. drug distributor AmerisourceBergen Corp, the Wall Street Journal reported on Monday.
* WALGREENS IN EARLY-STAGE TALKS TO BUY AMERISOURCEBERGEN, OF WHICH IT ALREADY OWNS 26 PERCENT - CNBC,CITING DJ
AmerisourceBergen Corp <ABC.N> on Tuesday said it received a grand jury subpoena from U.S. prosecutors seeking documents related to laboratory testing procedures at a facility that produces around half of the compounded drugs it supplies.
* AMERISOURCEBERGEN CORP CFO SAYS MEMPHIS FACILITY REMAINS CLOSED AND CURRENTLY ANTICIPATE OPERATIONS WILL RESUME THIS QUARTER - CONF CALL
* AMERISOURCEBERGEN REPORTS FISCAL 2018 FIRST QUARTER RESULTS
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.